Pharmafile Logo
Pharmafocus logo
Advanced Search

Q2

Showing 15 posts of 44 posts found.

Sanofi image

Sanofi sales slide on patent cliff woes

August 1, 2013
Sales and Marketing Aprovel, Plavix, Q2, Sanofi

Sanofi has been hit by generic erosion for key drugs in the second quarter, but the firm is confident it …

News
Pfizer image

Lipitor competition holds Pfizer back

July 31, 2013
Sales and Marketing Lipitor, Pfizer, Prevnar, Q2

Pfizer’s revenues in the second quarter of 2013 fell 7% year-on-year, in part due to the loss of patent in …

News
Merck image

Merck sees sales dip

July 31, 2013
Sales and Marketing Merck, Q2, Singulair, sales

A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …

News
BMS image

Sharp fall in sales for Bristol-Myers Squibb

July 26, 2013
Sales and Marketing Avapro, BMS, Plavix, Q2

Bristol-Myers Squibb has seen a fall in sales over the past three months as it struggles with major patent losses. …

News
Lilly image

Lilly beats estimates with solid Q2 performance

July 26, 2013
Sales and Marketing Q2, cymbalta, lilly, zyprexa

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …

News
Roche image

Strong growth for Roche in latest results

July 25, 2013
Sales and Marketing Alexion, Q2, Rituxan, Roche

Roche has seen strong sales growth in the past six months as it lines up new products to replace its …

News
gsk image

GSK sales up – impact of China allegations to follow

July 24, 2013
Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency

GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …

News

Marginal sales increase for Abbott

July 18, 2013
Sales and Marketing AbbVie, Abbott, Q2

Abbott’s second quarter results saw the company buffeted by currency exchange issues – primarily the yen weakening against the US …

News
J&J image

J&J sees Q2 sales rise

July 17, 2013
Sales and Marketing Elan, J&J, JJ, Q2, Synthes, sales

Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …

News
Shire image

Shire posts strong quarter results

August 2, 2012
Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

News

Lipitor loss continues to hit Pfizer sales

July 31, 2012
Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …

News

Bayer raises guidance after strong sales

July 31, 2012
Sales and Marketing Bayer, Nexavar, Q2, Xarelto, Yasmin

The Bayer Group has raised its full-year guidance for 2012 following positive results in the second quarter. This is despite …

News
Merck image

Merck sees growth in second quarter

July 30, 2012
Sales and Marketing Cozaar, Merck, Q2, Singulair

Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …

News
Astrazeneca image

AstraZeneca sees big sales drop in Q2

July 26, 2012
Sales and Marketing AstraZeneca, Brennan, Brilinta, Q2, Seroquel

AstraZeneca has today reported a large drop in revenue for the second quarter. The firm has been hit by major …

News

GSK falters in Q2 as austerity measures bite

July 25, 2012
Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty

GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026